Ubiquitin ligase Cbl-b represses IGF-I-induced epithelial mesenchymal transition via ZEB2 and microRNA-200c regulation in gastric cancer cells

Molecular Cancer

Volumn 13, Issue 1, 2014, Pages

  Li, Heming ^a   Xu, Ling ^a   Li, Ce ^a   Zhao, Lei ^a   Ma, Yanju ^a   Zheng, Huachuan ^b   Li, Zhi ^a   Zhang, Ye ^a   Wang, Ruoyu ^c   Liu, Yunpeng ^a   Qu, Xiujuan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b JINZHOU MEDICAL UNIVERSITY   (China)

^c DALIAN UNIVERSITY   (China)

Author keywords

Cbl b; EMT; IGF I; microRNA 200c; ZEB2

Indexed keywords

MICRORNA 200C; SHORT HAIRPIN RNA; SOMATOMEDIN C; TRANSCRIPTION FACTOR; TRANSCRIPTION ZEB2; UBIQUITIN LIGASE CBL B; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; CBL PROTEIN; CBLB PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; MICRORNA; MIRN200 MICRORNA, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; PROTEIN KINASE INHIBITOR; REPRESSOR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SMALL INTERFERING RNA; ZEB2 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GASTRIC CANCER CELL LINE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LYMPH NODE METASTASIS; PLASMID; PRIMARY TUMOR; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH ADENOCARCINOMA; STOMACH CANCER; UPREGULATION; WESTERN BLOTTING; ADENOCARCINOMA; AGED; ANTAGONISTS AND INHIBITORS; CANCER STAGING; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; SIGNAL TRANSDUCTION; STOMACH TUMOR; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOCARCINOMA; AGED; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM STAGING; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-CBL; REPRESSOR PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 84902294127     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-13-136     Document Type: Article

References (38)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249. 10.3322/caac.20006, 19474385.
2. Wagner AD, Grothe W, Haerting J, Kleber G, Grothey A, Fleig WE. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol 2006, 24:2903-2909. 10.1200/JCO.2005.05.0245, 16782930.
3. Chen W, Zheng R, Zhang S, Zhao P, Li G, Wu L, He J. The incidences and mortalities of major cancers in China, 2009. Chin J Cancer 2013, 32:106-112. 10.5732/cjc.013.10018, 3845591, 23452393.
4. Zhao L, Li W, Zang W, Liu Z, Xu X, Yu H, Yang Q, Jia J. JMJD2B promotes Epithelial-Mesenchymal Transition by cooperating with β-Catenin and enhances gastric cancer metastasis. Clin Cancer Res 2013, 19:6419-6429. 10.1158/1078-0432.CCR-13-0254, 24077348.
5. Walsh LA, Damjanovski S. IGF-1 increases invasive potential of MCF 7 breast cancer cells and induces activation of latent TGF-β1 resulting in epithelial to mesenchymal transition. Cell Commun Signal 2011, 9:10. 10.1186/1478-811X-9-10, 3104381, 21535875.
6. Graham TR, Zhau HE, Odero-Marah VA, Osunkoya AO, Kimbro KS, Tighiouart M, Liu T, Simons JW, O'Regan RM. Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Res 2008, 68:2479-2488. 10.1158/0008-5472.CAN-07-2559, 18381457.
7. Nagai T, Arao T, Furuta K, Sakai K, Kudo K, Kaneda H, Tamura D, Aomatsu K, Kimura H, Fujita Y, Matsumoto K, Saijo N, Kudo M, Nishio K. Sorafenib inhibits the hepatocyte growth factor-mediated epithelial mesenchymal transition in hepatocellular carcinoma. Mol Cancer Ther 2011, 10:169-177. 10.1158/1535-7163.MCT-10-0544, 21220499.
8. Thompson EW, Newgreen DF. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?. Cancer Res 2005, 65:5991-5995.
9. Franciosi CM, Piacentini MG, Conti M, Romano F, Musco F, Caprotti R, Rovelli F, Uggeri F. IGF-1 and IGF-1BP3 in gastric adenocarcinoma. Preliminary study. Hepatogastroenterology 2003, 50:297-300.
10. Ge J, Chen Z, Wu S, Chen J, Li X, Li J, Yin J, Chen Z. Expression levels of insulin-like growth factor-1 and multidrug resistance-associated protein-1 indicate poor prognosis in patients with gastric cancer. Digestion 2009, 80:148-158. 10.1159/000226089, 19713703.
11. Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 2002, 82:373-428.
12. Voutsadakis IA. The ubiquitin-proteasome system and signal transduction pathways regulating Epithelial Mesenchymal transition of cancer. J Biomed Sci 2012, 9:67.
13. Li Y, Qu X, Qu J, Ye Z, Jing L, Yuee T, Xuejun H, Kezuo H, Yunpeng L. E3 ubiquitin ligase Cbl-b potentiates the apoptotic action of arsenic trioxide by inhibiting the PI3K/Akt pathway. Braz J Med Biol Res 2011, 44:105-111. 10.1590/S0100-879X2010007500142, 21180886.
14. Qu X, Li Y, Liu J, Xu L, Zhang Y, Hu X, Hou K, Liu Y. Cbl-b promotes chemotherapy-induced apoptosis in rat basophilic leukemia cells by suppressing PI3K/Akt activation and enhancing MEK/ERK activation. Mol Cell Biochem 2010, 340:107-114. 10.1007/s11010-010-0407-8, 20177738.
15. Xu L, Zhang Y, Liu J, Qu J, Hu X, Zhang F, Zheng H, Qu X, Liu Y. TRAIL-activated EGFR by Cbl-b-regulated EGFR redistribution in lipid rafts antagonizes TRAIL-induced apoptosis in gastric cancer cells. Eur J Cancer 2012, 48:3288-3299. 10.1016/j.ejca.2012.03.005, 22456178.
16. Duan L, Raja SM, Chen G, Virmani S, Williams SH, Clubb RJ, Mukhopadhyay C, Rainey MA, Ying G, Dimri M, Chen J, Reddi AL, Naramura M, Band V, Band H. Negative regulation of EGFR-Vav2 signaling axis by Cbl ubiquitin ligase controls EGF receptor-mediated epithelial cell adherens junction dynamics and cell migration. J Biol Chem 2011, 286:620-633. 10.1074/jbc.M110.188086, 3013022, 20940296.
17. Qu X, Liu Y, Ma Y, Zhang Y, Li Y, Hou K. Up-regulation of the Cbl family of ubiquitin ligases is involved in ATRA and bufalin-induced cell adhesion but not cell differentiation. Biochem Biophys Res Commun 2008, 367:183-189. 10.1016/j.bbrc.2007.12.120, 18164258.
18. Nakao R, Hirasaka K, Goto J, Ishidoh K, Yamada C, Ohno A, Okumura Y, Nonaka I, Yasutomo K, Baldwin KM, Kominami E, Higashibata A, Nagano K, Tanaka K, Yasui N, Mills EM, Takeda S, Nikawa T. Ubiquitin ligase Cbl-b is a negative regulator for insulin-like growth factor 1 signaling during muscle atrophy caused by unloading. Mol Cell Biol 2009, 29:4798-4811. 10.1128/MCB.01347-08, 2725709, 19546233.
19. Xu L, Qu X, Hu X, Zhu Z, Li C, Li E, Ma Y, Song N, Liu Y. Lipid raft-regulated IGF-1R activation antagonizes TRAIL-induced apoptosis in gastric cancer cells. FEBS Lett 2013, 587:3815-3823. 10.1016/j.febslet.2013.10.007, 24161672.
20. Qu X, Zhang Y, Li Y, Hu X, Xu Y, Xu L, Hou K, Sada K, Liu Y. Ubiquitin ligase Cbl-b sensitizes leukemia and gastric cancer cells to anthracyclines by activating the mitochondrial pathway and modulating Akt and ERK survival signals. FEBS Lett 2009, 583:2255-2262. 10.1016/j.febslet.2009.05.054, 19508871.
21. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB and SIP1. Nat Cell Biol 2008, 10:593-601. 10.1038/ncb1722, 18376396.
22. Fournier TM, Lamorte L, Maroun CR, Lupher M, Band H, Langdon W, Park M. Cbl-transforming variants trigger a cascade of molecular alterations that lead to epithelial mesenchmal conversion. Mol Biol Cell 2000, 11:3397-3410. 10.1091/mbc.11.10.3397, 15002, 11029044.
23. Levkowitz G, Waterman H, Ettenberg SA, Katz M, Tsygankov AY, Alroy I, Lavi S, Iwai K, Reiss Y, Ciechanover A, Lipkowitz S, Yarden Y. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. Mol Cell 1999, 4:1029-1040. 10.1016/S1097-2765(00)80231-2, 10635327.
24. Sehat B, Andersson S, Girnita L, Larsson O. Identification of c-Cbl as a new ligase for Insulin-like growth factor-I receptor with distinct roles from Mdm2 in receptor ubiquitination and endocytosis. Cancer Res 2008, 68:5669-5677. 10.1158/0008-5472.CAN-07-6364, 18632619.
25. Kim HJ, Litzenburger BC, Cui X, Delgado DA, Grabiner BC, Lin X, Lewis MT, Gottardis MM, Wong TW, Attar RM, Carboni JM, Lee AV. Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelial-to-mesenchymal transition mediated by NF-kappa B and snail. Mol Cell Biol 2007, 27:3165-3175. 10.1128/MCB.01315-06, 1899918, 17296734.
26. Irie HY, Pearline RV, Grueneberg D, Hsia M, Ravichandran P, Kothari N, Natesan S, Brugge JS. Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J Cell Biol 2005, 171:1023-1034. 10.1083/jcb.200505087, 2171329, 16365168.
27. Postigo AA, Dean DC. Differential expression and function of members of the zfh-1 family of zinc finger/homeodomain repressors. Proc Natl Acad Sci U S A 2000, 97:6391-6396. 10.1073/pnas.97.12.6391, 18613, 10841546.
28. Miyoshi A, Kitajima Y, Sumi K, Sato K, Hagiwara A, Koga Y, Miyazaki K. Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells. Br J Cancer 2004, 90:1265-1273. 10.1038/sj.bjc.6601685, 2409652, 15026811.
29. Remacle JE, Kraft H, Lerchner W, Wuytens G, Collart C, Verschueren K, Smith JC, Huylebroeck D. New mode of DNA binding of multi-zinc finger transcription factors: deltaEF1 family members bind with two hands to two target sites. EMBO J 1999, 18:5073-5084. 10.1093/emboj/18.18.5073, 1171578, 10487759.
30. Elloul S, Elstrand MB, Nesland JM, Tropé CG, Kvalheim G, Goldberg I, Reich R, Davidson B. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Cancer 2005, 103:1631-1643. 10.1002/cncr.20946, 15742334.
31. Yu J, Ohuchida K, Mizumoto K, Sato N, Kayashima T, Fujita H, Nakata K, Tanaka M. MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation. Mol Cancer 2010, 9:169. 10.1186/1476-4598-9-169, 2909980, 20579395.
32. Romero-Pérez L, López-García M, Díaz-Martín J, Biscuola M, Castilla M, Tafe LJ, Garg K, Oliva E, Matias-Guiu X, Soslow RA, Palacios J. ZEB1 overexpression associated with E-cadherin and microRNA-200 down-regulation is characteristic of undifferentiated endometrial carcinoma. Mod Pathol 2013, 26:1514-1524. 10.1038/modpathol.2013.93, 23743934.
33. Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, Shannon MF, Goodall GJ. A double-negative feedback loop between ZEB1-SIP1 and the microRNA- 200 family regulates epithelial-mesenchymal transition. Cancer Res 2008, 68:7846-7854. 10.1158/0008-5472.CAN-08-1942, 18829540.
34. Korpal M, Lee ES, Hu G, Kang Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 2008, 283:14910-14914. 10.1074/jbc.C800074200, 3258899, 18411277.
35. Wang X, Chen X, Wang R, Xiao P, Xu Z, Chen L, Hang W, Ruan A, Yang H, Zhang X. microRNA-200c modulates the eptithelial-to-mesenchymal transition in human renal cell carcinoma metastasis. Oncol Rep 2013, 30:643-650.
36. Hicke L. Gettin' down with ubiquitin: turning off cell-surface receptors, transporters and channels. Trends Cell Biol 1999, 9:107-112. 10.1016/S0962-8924(98)01491-3, 10201076.
37. Yokouchi M, Kondo T, Houghton A, Bartkiewicz M, Horne WC, Zhang H, Yoshimura A, Baron R. Ligand-induced ubiquitination of the epidermal growth factor receptor involves the interaction of the c-Cbl RING finger and UbcH7. J Biol Chem 1999, 274:31707-31712. 10.1074/jbc.274.44.31707, 10531381.
38. Thomas C, Rajapaksa G, Nikolos F, Hao R, Katchy A, McCollum CW, Bondesson M, Quinlan P, Thompson A, Krishnamurthy S, Esteva FJ, Gustafsson JA. ERβ1 represses basal-like breast cancer epithelial to mesenchymal transition by destabilizing EGFR. Breast Cancer Res 2012, 14:R148. 10.1186/bcr3358, 23158001.